These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
7. Is it true that drinking lemonade helps prevent kidney stones? Mayo Clin Womens Healthsource; 2006 Nov; 10(11):10. PubMed ID: 17047570 [No Abstract] [Full Text] [Related]
8. The effects of grapefruit juice on the pharmacokinetics of erythromycin. Kanazawa S; Ohkubo T; Sugawara K Eur J Clin Pharmacol; 2001; 56(11):799-803. PubMed ID: 11294369 [TBL] [Abstract][Full Text] [Related]
9. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. Damkier P; Hansen LL; Brosen K Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487 [TBL] [Abstract][Full Text] [Related]
10. Nutrient intake and use of beverages and the risk of kidney stones among male smokers. Hirvonen T; Pietinen P; Virtanen M; Albanes D; Virtamo J Am J Epidemiol; 1999 Jul; 150(2):187-94. PubMed ID: 10412964 [TBL] [Abstract][Full Text] [Related]
11. Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones. Gasińska A; Gajewska D Rocz Panstw Zakl Hig; 2007; 58(1):61-7. PubMed ID: 17711092 [TBL] [Abstract][Full Text] [Related]
12. Drug interactions with grapefruit juice. Ameer B; Weintraub RA Clin Pharmacokinet; 1997 Aug; 33(2):103-21. PubMed ID: 9260034 [TBL] [Abstract][Full Text] [Related]
13. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. Yasui N; Kondo T; Furukori H; Kaneko S; Ohkubo T; Uno T; Osanai T; Sugawara K; Otani K Psychopharmacology (Berl); 2000 Jun; 150(2):185-90. PubMed ID: 10907671 [TBL] [Abstract][Full Text] [Related]
14. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. Proppe DG; Hoch OD; McLean AJ; Visser KE Br J Clin Pharmacol; 1995 Mar; 39(3):337-8. PubMed ID: 7619679 [No Abstract] [Full Text] [Related]
15. Prospective study of beverage use and the risk of kidney stones. Curhan GC; Willett WC; Rimm EB; Spiegelman D; Stampfer MJ Am J Epidemiol; 1996 Feb; 143(3):240-7. PubMed ID: 8561157 [TBL] [Abstract][Full Text] [Related]
16. Grapefruit juice and kidney stones. Ameer B Ann Intern Med; 1998 Dec; 129(11):913. PubMed ID: 9867737 [No Abstract] [Full Text] [Related]
17. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Min DI; Ku YM; Perry PJ; Ukah FO; Ashton K; Martin MF; Hunsicker LG Transplantation; 1996 Jul; 62(1):123-5. PubMed ID: 8693526 [TBL] [Abstract][Full Text] [Related]
18. [Study on beverages and kidney stone disease]. Miyazawa K; Suzuki K Hinyokika Kiyo; 2004 Aug; 50(8):577-81. PubMed ID: 15471080 [TBL] [Abstract][Full Text] [Related]
19. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Dresser GK; Wacher V; Wong S; Wong HT; Bailey DG Clin Pharmacol Ther; 2002 Sep; 72(3):247-55. PubMed ID: 12235445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]